Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 8430637, 8 pages
http://dx.doi.org/10.1155/2016/8430637
Research Article

N-11C-Methyl-Dopamine PET Imaging of Sympathetic Nerve Injury in a Swine Model of Acute Myocardial Ischemia: A Comparison with 13N-Ammonia PET

1Department of Nuclear Medicine, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, China
2Department of Anesthesiology, Affiliated People’s Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010020, China

Received 24 November 2015; Accepted 6 January 2016

Academic Editor: James Russell

Copyright © 2016 Weina Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. O. Bonow, L. A. Smaha, S. C. Smith Jr., G. A. Mensah, and C. Lenfant, “World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic,” Circulation, vol. 106, no. 13, pp. 1602–1605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Stanton, M. M. Tuli, N. L. Radtke et al., “Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine,” Journal of the American College of Cardiology, vol. 14, no. 6, pp. 1519–1526, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. A. I. McGhie, J. R. Corbett, M. S. Akers et al., “Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction,” The American Journal of Cardiology, vol. 67, no. 4, pp. 236–242, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. M. W. Dae, J. M. Herre, J. W. O'Connell, E. H. Botvinick, D. Newman, and L. Munoz, “Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction,” Journal of the American College of Cardiology, vol. 17, no. 6, pp. 1416–1423, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Simula, T. Lakka, T. Laitinen et al., “Cardiac adrenergic denervation in patients with non-Q-wave versus Q-wave myocardial infarction,” European Journal of Nuclear Medicine, vol. 27, no. 7, pp. 816–821, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Kawai, E. Tsukamoto, Y. Nozaki, K. Morita, M. Sakurai, and N. Tamaki, “Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain,” Journal of the American College of Cardiology, vol. 38, no. 7, pp. 1888–1894, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Watanabe, T. Takahashi, S. Miyajima et al., “Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina,” Journal of Nuclear Medicine, vol. 43, no. 11, pp. 1476–1481, 2002. View at Google Scholar · View at Scopus
  8. D. M. Raffel and D. M. Wieland, “Assessment of cardiac sympathetic nerve integrity with positron emission tomography,” Nuclear Medicine and Biology, vol. 28, no. 5, pp. 541–559, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Joho, H. Asanoi, J. Takagawa et al., “Cardiac sympathetic denervation modulates the sympathoexcitatory response to acute myocardial ischemia,” Journal of the American College of Cardiology, vol. 39, no. 3, pp. 436–442, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. F. M. Bengel and M. Schwaiger, “Assessment of cardiac sympathetic neuronal function using PET imaging,” Journal of Nuclear Cardiology, vol. 11, no. 5, pp. 603–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Sakata, M. Shirotani, H. Yoshida, and C. Kurata, “Iodine-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing,” Journal of the American College of Cardiology, vol. 30, no. 2, pp. 370–376, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Inobe, K. Kugiyama, H. Miyagi et al., “Long-lasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy,” American Heart Journal, vol. 134, no. 1, pp. 112–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Cohen-Solal, F. Rouzet, A. Berdeaux et al., “Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure,” Journal of Nuclear Medicine, vol. 46, no. 11, pp. 1796–1803, 2005. View at Google Scholar · View at Scopus
  14. S. Yamashina and J.-I. Yamazaki, “Neuronal imaging using SPECT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, supplement 1, pp. S62–S73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Lautamäki, D. Tipre, and F. M. Bengel, “Cardiac sympathetic neuronal imaging using PET,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, supplement 1, pp. S74–S85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. M. Bengel, “Imaging targets of the sympathetic nervous system of the heart: translational considerations,” Journal of Nuclear Medicine, vol. 52, no. 8, pp. 1167–1170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Wieland, L. E. Brown, W. L. Rogers et al., “Myocardial imaging with a radioiodinated norepinephrine storage analog,” Journal of Nuclear Medicine, vol. 22, no. 1, pp. 22–31, 1981. View at Google Scholar · View at Scopus
  18. M. Schwaiger, V. Kalff, K. Rosenspire et al., “Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography,” Circulation, vol. 82, no. 2, pp. 457–464, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Raffel and D. M. Wieland, “Assessment of cardiac sympathetic nerve integrity with positron emission tomography,” Nuclear Medicine and Biology, vol. 28, no. 5, pp. 541–559, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. K. S. Jang, Y.-W. Jung, P. S. Sherman, C. A. Quesada, G. Gu, and D. M. Raffel, “Synthesis and bioevaluation of [18F]4-fluoro-m-hydroxyphenethylguanidine ([18F]4F-MHPG): a novel radiotracer for quantitative PET studies of cardiac sympathetic innervation,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 6, pp. 1612–1616, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Ilias, C. C. Chen, J. A. Carrasquillo et al., “Comparison of 6-18F-fluorodopamine PET with 123I- metaiodobenzylguanidine and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma,” Journal of Nuclear Medicine, vol. 49, no. 10, pp. 1613–1619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. L. M. Timmers, C. C. Chen, J. A. Carrasquillo et al., “Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 4757–4767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. L. He, W. N. Zhou, X. C. Wang et al., “The synthesis of a new cardiac sympathetic nerve imaging agent N-[11C]CH3-dopamine and biodistribution study,” Journal of Radioanalytical and Nuclear Chemistry, vol. 301, no. 2, pp. 469–474, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Hartikainen, J. Mustonen, J. Kuikka, E. Vanninen, and R. Kettunen, “Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction,” American Journal of Cardiology, vol. 80, no. 3, pp. 273–277, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. H. P. Bülow, F. Stahl, B. Lauer et al., “Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction,” Nuclear Medicine Communications, vol. 24, no. 3, pp. 233–239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Matsunari, U. Schricke, F. M. Bengel et al., “Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes,” Circulation, vol. 101, no. 22, pp. 2579–2585, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. M. V. Simões, P. Barthel, I. Matsunari et al., “Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction,” European Heart Journal, vol. 25, no. 7, pp. 551–557, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. E. L. Fallen, G. Coates, C. Nahmias et al., “Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction,” American Heart Journal, vol. 137, no. 5, pp. 863–869, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. H. V. Huikuri, M. J. P. Raatikainen, R. Moerch-Joergensen et al., “Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction,” European Heart Journal, vol. 30, no. 6, pp. 689–698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. D. S. Goldstein, B. Eldadah, Y. Sharabi, and F. B. Axelrod, “Cardiac sympathetic hypo-innervation in familial dysautonomia,” Clinical Autonomic Research, vol. 18, no. 3, pp. 115–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Sasano, M. R. Abraham, K.-C. Chang et al., “Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction,” Journal of the American College of Cardiology, vol. 51, no. 23, pp. 2266–2275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. P. Zipes and M. Rubart, “Neural modulation of cardiac arrhythmias and sudden cardiac death,” Heart Rhythm, vol. 3, no. 1, pp. 108–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. P. J. Schwartz, “The autonomic nervous system and sudden death,” European Heart Journal, vol. 19, supplement F, pp. F72–F80, 1998. View at Google Scholar · View at Scopus
  34. M. Packer, “The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure,” Journal of the American College of Cardiology, vol. 20, no. 1, pp. 248–254, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. D. J. Ewing, “Diabetic autonomic neuropathy and the heart,” Diabetes Research and Clinical Practice, vol. 30, supplement, pp. 31–36, 1996. View at Publisher · View at Google Scholar · View at Scopus